1. Medtech Insight

Siemens Healthineers To Spend €160M Building R&D And Manufacturing Hub In India

 
• By Phil Greenfield

The company is the second big medtech to announce a major investment in R&D in the country in 2020.

Two Businessmen Shaking Hands With Flag of India
• Source: Shutterstock

Siemens Healthineers AG will invest €160m ($189m) over five years to develop its “innovation hub” in India and will also add 1,800 experts in data analytics, artificial intelligence and immersive technologies over the next 10 years as part of a drive into emerging markets in Southeast Asia, Africa, Eastern Europe, and South America.

The investment, which is the company’s biggest in India and brings the total invested there to around €460m, follows the August 2020 announcement by Medtronic plc that it is...

More from Asia

More from Geography

UK Take Care! Regulatory And Market Access Reforms Must Not Shut Out Medtech Growth

 
• By Ashley Yeo

Speakers at a recent UK medtech outlook conference voiced optimism about the sector’s prospects, but warned that cost burdens, over-regulation and lengthy processes will impede the capacity of local SMEs to innovate. Only 10% of NHS procured medtech comes from UK manufacturers.

Roche Diagnostics Day 2025: ‘We Need To Become A Leader In Decentralized Testing’

 
• By Natasha Barrow

Roche aims to grow its diagnostics sales by mid to high single digits, said CEO of Roche Diagnostics Matt Sause. The company unveiled the Axelios synthesis and sequencing solution and discussed its “long-term commitment” to China, as well as its business strategy for the next five years.

Zika Virus Test Among 4 New FDA Device Classifications

 
• By Elizabeth Orr

The FDA plans to announce class II status for four new device types, including tests for the Zika virus and genetic condition Fragile X. This follows earlier announcements and highlights a trend toward diagnostic classifications. The classifications are considered deregulatory, meaning they will hel